Docetaxel suppressed cell proliferation through Smad3/HIF-1α-mediated glycolysis in prostate cancer cells

BACKGROUND: Tumor glycolysis is a critical event for tumor progression. Docetaxel is widely used as a first-line drug for chemotherapy and shown to have a survival advantage. However, the role of docetaxel in tumor glycolysis remained poorly understood. METHODS: The effect of Docetaxel in tumor glyc...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Junming, He, Zhijun, Yuan, Yeqing, Xie, Jing, Zhou, Yu, Guo, Baochun, Guo, Jinan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9762006/
https://www.ncbi.nlm.nih.gov/pubmed/36536346
http://dx.doi.org/10.1186/s12964-022-00950-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9762006/
https://www.ncbi.nlm.nih.gov/pubmed/36536346
http://dx.doi.org/10.1186/s12964-022-00950-z

Ejemplares similares